{
    "name": "carglumic acid",
    "comment": "Rx",
    "other_names": [
        "Carbaglu"
    ],
    "classes": [
        "Urea Cycle Disorder Treatment Agents"
    ],
    "source": "https://reference.medscape.com/drug/carbaglu-carglumic-acid-999487",
    "pregnancy": {
        "common": [
            "Rare case reports of use in pregnant women are insufficient to inform a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes",
            "Pregnancy pharmacovigilance program for carglumic acid exposures: 1-888-575-8344",
            "Pregnant females with urea cycle disorders may experience an increase in catabolic stress which can trigger a hyperammonemic crisis both in intrapartum and in postpartum (3-14 days post-partum) periods",
            "Maternal complications related to hyperammonemic crisis can include neurological impairment, coma and in some cases death"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Decreased survival and growth occurred in offspring born to rats that received carglumic acid at a dose ~38x maximum reported human maintenance dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Unknown whether drug is excreted in human milk",
            "Present in rat milk, and an increase in mortality and impairment of body weight gain occurred in neonatal rats nursed by mothers receiving carglumic acid",
            "Breastfeeding is not recommended during therapy; treatment is continuous and life-long for NAGS deficiency patients"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Plasma concentrations of carglumic acid increased in patients with renal impairment; reduce the dosage in patients with moderate or severe renal impairment; the pharmacokinetics of carglumic acid have not been evaluated in patients with end stage renal disease"
            ],
            "specific": [
                {
                    "type": "Hyperammonemia",
                    "description": [
                        "Monitor serum ammonia levels and adjust dose to maintain within normal range for age",
                        "Treat acute hyperammonemia episode as life-threatening emergency",
                        "Treatment of severe hyperammonemia may require dialysis, preferably hemodialysis and/or hemofiltration, to reduce plasma ammonia concentration",
                        "Untreated hyperammonemia can result in brain damage and death, and prompt use of all therapies necessary to reduce plasma ammonia level is essential",
                        "Protein restriction during an acute hyperammonemic episode is recommended for no longer than 12-36 hr while maximizing caloric supplementation to reverse catabolism; protein should be reintroduced as early as possible, following improvement of metabolic and clinical abnormalities in this setting; during long-term management, dietary protein restriction should be instituted to maintain blood ammonia level within an acceptable range for age",
                        "Ongoing monitoring of plasma ammonia level, neurological status, growth parameters, protein intake/nutritional status (both during acute hyperammonemic episodes and long-term), and relevant laboratory tests in patients receiving therapy should be part of evaluating clinical response to treatment"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Vomiting",
            "percent": "26"
        },
        {
            "name": "Abdominal pain",
            "percent": "17"
        },
        {
            "name": "Pyrexia",
            "percent": "17"
        },
        {
            "name": "Tonsillitis",
            "percent": "17"
        },
        {
            "name": "Anemia",
            "percent": "13"
        },
        {
            "name": "Diarrhea",
            "percent": "13"
        },
        {
            "name": "Ear infection",
            "percent": "13"
        },
        {
            "name": "Infections",
            "percent": "13"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "13"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "13"
        },
        {
            "name": "Headache",
            "percent": "13"
        },
        {
            "name": "Neutropenia",
            "percent": "14"
        },
        {
            "name": "Anemia",
            "percent": "12"
        },
        {
            "name": "Dysgeusia",
            "percent": "9"
        },
        {
            "name": "Asthenia",
            "percent": "9"
        },
        {
            "name": "Hyperhidrosis",
            "percent": "9"
        },
        {
            "name": "Influenza",
            "percent": "9"
        },
        {
            "name": "Pneumonia",
            "percent": "9"
        },
        {
            "name": "Weight decreased",
            "percent": "9"
        },
        {
            "name": "Anorexia",
            "percent": "9"
        },
        {
            "name": "Somnolence",
            "percent": "9"
        },
        {
            "name": "Rash",
            "percent": "9"
        },
        {
            "name": "Vomiting",
            "percent": "7"
        },
        {
            "name": "Electrolyte imbalance",
            "percent": "7"
        },
        {
            "name": "Decreased appetite",
            "percent": "5"
        },
        {
            "name": "Hypoglycemia",
            "percent": "5"
        },
        {
            "name": "Lethargy",
            "percent": "5"
        },
        {
            "name": "stupor",
            "percent": "5"
        },
        {
            "name": "Encephalopathy",
            "percent": "5"
        },
        {
            "name": "Pancreatitis",
            "percent": "2"
        },
        {
            "name": "lipase increased",
            "percent": "2"
        },
        {
            "name": "Cardiomyopathy",
            "percent": "2"
        },
        {
            "name": "Alanine aminotransferase increased",
            "percent": "2"
        },
        {
            "name": "Aspartate aminotransferase increased",
            "percent": "2"
        },
        {
            "name": "Infusion site extravasation",
            "percent": "2"
        },
        {
            "name": "White blood cell count increased",
            "percent": "2"
        },
        {
            "name": "Behavior disorder",
            "percent": "2"
        },
        {
            "name": "Sleep disorder",
            "percent": "2"
        },
        {
            "name": "Apnea",
            "percent": null
        },
        {
            "name": "Hyperventilation",
            "percent": null
        }
    ]
}